. Author manuscript; available in PMC: 2021 Feb 1.

Published in final edited form as: Cancer. 2019 Oct 29;126(3):593–601. doi: 10.1002/cncr.32552

Table 3:

Complete remission rates at end of induction by starting therapy and MPAL phenotype

Characteristic		CR		No CR		p-value^†
Characteristic		N	%^†	N	%^†	p-value^†
Starting therapy	ALL	28	71.8	11	28.2	1.000
	AML	9	69.2	4	30.8
	Hybrid	2	100.0	0	0.0
MPAL Phenotype^‡	B/Myeloid	26	78.8	7	21.2	0.074
	T/Myeloid	13	68.4	6	31.6
	B/T	0	0.0	2	100.0

^†

Fisher’s exact test. % each characteristic.

^‡

No patients in the cohort were B/T/Myeloid.

CR= complete remission (leukemia blasts <5% in the bone marrow without extramedullary disease).